This patented, innovative prECM™ technology processes donated human tissue removing cellular components (source of rejection) while leaving the structural protein matrix of the tissue intact. During processing, potential bacteria and viruses are also deactivated and removed resulting in a sterile, safe, and effective biological scaffold that promotes tissue regeneration when implanted into a patient.